The Fund Grade · free · no account needed
What grade does ETAGX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Eventide Gilead A
#125 of 500 graded active funds · blend · mid segment peer group
The point · specialist footprint
ETAGX puts less of its book behind proven specialists than 70% of graded funds.
Bottom 20%
● Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
ETAGX vs the Honor Roll · share card ↗Conviction exposure
11.5%
of the book in specialist-converged names
Late-stage weight
30%
of the book in Crowded or Fading names
Active share
96.4%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
Eventide Gilead A earns a B grade, ranking 125 of 500 graded funds, with specialists holding about 11.5% of the fund. The early story here is LRCX and TT, where proven specialists are still building positions. Watch the fading side though, ASML, ODFL, and MIRM together represent meaningful weight that specialist money is actively leaving.
→ Monitor ASML, ODFL, and MIRM closely, as specialists are fading from all three positions totaling nearly 9% of the fund.
→ Note that LRCX at 4.1% and TT at 2.9% are Early Conviction stages, where the evidence suggests specialists are genuinely early.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.